Skip to Content
Biotechnology

A brain-controlled exoskeleton has let a paralyzed man walk in the lab

October 4, 2019
Man in exosketeton
Man in exosketeton
Man in exosketetonFonds de Donation Clinatec

The news: A paralyzed man has walked again thanks to a brain-controlled exoskeleton suit. Within the safety of a lab setting, he was also able to control the suit’s arms and hands, using two sensors on his brain. The patient was a man from Lyon named Thibault, who fell 40 feet (12 meters) from a balcony four years ago, leaving him paralyzed from the shoulders down.  

How it worked: Thibault had surgery to place two implants, each containing 64 electrodes, on the parts of the brain that control movement. Software then translated the brain waves read by these implants into instructions for movement. The development of the exoskeleton, by Clinatec and the University of Grenoble, is described in a paper in The Lancet this week.

Herculean effort: Thibault trained for months, using his brain signals to control a video game avatar in order to hone the skills required to operate exoskeleton, which was held up by a ceiling-mounted harness. He was able to walk slowly in the suit and then stop, as he chose.

The future: The hope is that one day similar technology could eventually let people in wheelchairs move them using their minds. It’s an impressive breakthrough, but the device is many years away from being publicly available. For example, researchers need to find a way to get the suit to safely balance itself before it can be used outside the laboratory.

Sign up here for our daily newsletter The Download to get your dose of the latest must-read news from the world of emerging tech.

Deep Dive

Biotechnology

He Jiankui
He Jiankui

The creator of the CRISPR babies has been released from a Chinese prison

He Jiankui created the first gene-edited children. The price was his career. And his freedom.

Aging Clocks concept
Aging Clocks concept

Aging clocks aim to predict how long you’ll live

These clocks promise to measure biological age and help identify anti-aging drugs, but there are lingering questions over their accuracy.

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.